Skip to main content
Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
38.41
+0.28 (0.73%)
At close: Mar 6, 2026

Novo Nordisk Revenue

In the year 2025, Novo Nordisk had annual revenue of 309.06B DKK with 6.43% growth. Novo Nordisk had revenue of 79.14B in the quarter ending December 31, 2025, a decrease of -7.63%.

Revenue
309.06B DKK
Revenue Growth
+6.43%
P/S Ratio
3.52
Revenue / Employee
4.45M DKK
Employees
69,505
Market Cap
171.00B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025309.06B18.66B6.43%
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Glass House Brands 196.17M
Elite Pharmaceuticals 140.12M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Tian'an Technology Group 2.12M
Vaxart 148.20M
Revenue Rankings

Novo Nordisk News

More News